Earnings History Data for MEI Pharma (MEIP) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
MEI Pharma
MEI Pharma, Inc. is an oncology company focused on the clinical development of novel therapeutics targeting cancer metabolism. The Company is focused on the clinical development of its two lead isoflavone-based drug candidates, ME-143 and ME-344. MEI Pharma, Inc., formerly known as Marshall Edwards, Inc., is based in San Diego.
Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
19-09-2024 | AH | MEIP | MEI Pharma | 20.00 | -1.13 | -1.48 | 0.00 | MEI Pharma GAAP EPS of $2.67 misses by $0.95, revenue of $65.3M in-line [9/19/2024 4:25 PM] |
2.98 | -0.16 (-4.94%) |
3.20 | 0.06 (1.91%) |
2.73 - 6.91 | 10,487 | 20,000 | 3,347 | ||
13-02-2024 | AH | MEIP | MEI Pharma | 32.00 | -1.66 | -1.46 | 0.00 | MEI Pharma GAAP EPS of -$1.66 misses by $0.25 [2/13/2024 5:19 PM] |
4.68 | 0.05 (1.08%) |
4.54 | -0.09 (-1.94%) |
3.11 - 6.91 | 20,863 | 20,000 | 8,364 | ||
09-11-2023 | AH | MEIP | MEI Pharma | 50.00 | 8.46 | -1.47 | 0.00 | MEI Pharma GAAP EPS of $8.46, revenue of $65.3M [11/9/2023 5:42 PM] |
7.21 | 0.15 (2.12%) |
7.40 | 0.34 (4.82%) |
4.00 - 8.60 | 22,377 | 40,000 | 9,550 | ||
26-09-2023 | AH | MEIP | MEI Pharma, Inc. | 50.30 | -1.51 | -3.25 | -2.40 | MEI Pharma GAAP EPS of -$4.78 beats by $0.92, revenue of $48.82M beats by $0.53M [9/26/2023 4:05 PM] |
7.19 | -0.15 (-2.04%) |
0.0 | 0.0 (0.00%) |
4.00 - 8.74 | 74,825 | 90,000 | 0 | ||
11-05-2023 | AH | MEIP | MEI Pharma | 48.00 | -2.32 | -2.60 | 0.00 | MEI Pharma Non-GAAP EPS of -$2.32 beats by $0.48, revenue of $5.89M beats by $5.43M [5/11/2023 5:12 PM] |
6.98 | 0.02 (0.32%) |
0.0 | 0.0 (0.00%) |
4.00 - 13.60 | 63,614 | 100,000 | 0 | ||
14-11-2022 | AH | MEIP | MEI Pharma | 42.00 | -0.13 | -0.13 | 0.00 | MEI Pharma GAAP EPS of -$0.12 beats by $0.04, revenue of $8.73M beats by $4.31M [11/14/2022 6:47 PM] |
0.3445 | 0.01 (4.39%) |
0.37 | 0.04 (11.82%) |
0.28 - 3.55 | 863,810 | 790,000 | 206 | ||
08-09-2022 | AH | 4:20 PM ET (Sep 8) |
MEIP | MEI Pharma, Inc. | 67.65 | -0.12 | -0.18 | 0.00 | MEI Pharma GAAP EPS of -$0.50 misses by $0.03, revenue of $40.7M misses by $1.09M [9/8/2022 4:15 PM] |
0.5394 | 0.01 (2.41%) |
0.53 | 0.0 (0.63%) |
0.41 - 3.55 | 748,762 | 690,000 | 29,083 | |
|
||||||||||||||||||
23-05-2022 | AH | MEIP | MEI Pharma | 62.00 | -0.17 | -0.17 | 0.00 | MEI Pharma GAAP EPS of -$0.07 beats by $0.11, revenue of $9.7M beats by $6.26M [5/23/2022 4:40 PM] |
0.4338 | -0.02 (-4.24%) |
0.46 | 0.01 (2.56%) |
0.43 - 3.55 | 2,025,764 | 3,000,000 | 37,463 | ||
10-11-2021 | AH | MEIP | MEI Pharma, Inc. | 364.04 | -0.13 | -0.13 | -0.25 | MEI Pharma EPS misses by $0.01, beats on revenue [11/10/2021 4:35 PM] |
3.16 | 0.17 (5.69%) |
2.99 | 0.0 (0.00%) |
2.40 - 4.58 | 432,320 | 490,000 | 6,020 | ||
|
||||||||||||||||||
02-09-2021 | AH | 4:05 PM ET (Sep 2) |
MEIP | MEI Pharma, Inc. | 315.26 | N/A | -0.15 | 0.14 | MEI Pharma EPS misses by $0.11, beats on revenue [9/2/2021 4:11 PM] |
2.89 | -0.01 (-0.34%) |
2.86 | -0.04 (-1.38%) |
2.29 - 4.58 | 394,665 | 240,000 | 1,830 | |
|
||||||||||||||||||
06-05-2021 | AH | MEIP | MEI Pharma, Inc. | 383.72 | -0.20 | -0.15 | -0.11 | MEI Pharma EPS misses by $0.12, misses on revenue [5/6/2021 5:10 PM] |
3.31 | -0.01 (-0.30%) |
3.31 | 0.0 (0.00%) |
2.29 - 4.58 | 515,124 | 600,000 | 8,773 | ||
04-02-2021 | AH | 4:05 PM ET (Feb 4) |
MEIP | MEI Pharma, Inc. | 390.45 | -0.22 | -0.15 | -0.15 | MEI Pharma EPS beats by $0.01, beats on revenue [2/4/2021 5:05 PM] |
3.99 | 0.60 (17.70%) |
3.42 | 0.03 (0.88%) |
0.72 - 4.46 | 3,647,716 | 911,034 | 13,090 | |
10-11-2020 | AH | MEIP | Mei Pharma, Inc. | 299.00 | -0.25 | -0.07 | 0.00 | MEI Pharma EPS misses by $0.06, beats on revenue [11/10/2020 4:34 PM] |
2.74 | -0.10 (-3.35%) |
2.80 | -0.04 (-1.41%) |
0.72 - 4.46 | 608,265 | 605,229 | 2,610 | ||
|
||||||||||||||||||
09-09-2020 | AH | 4:00 PM ET (Sep 9) |
MEIP | MEI Pharma, Inc. | 260.76 | 0.14 | 0.13 | -0.02 | MEI Pharma EPS misses by $0.36, misses on revenue [9/9/2020 4:08 PM] |
2.90 | 0.22 (8.40%) |
2.61 | -0.07 (-2.61%) |
0.72 - 4.46 | 1,040,909 | 789,398 | 1,074 | |
|